Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-26

Clinical Trial Update: Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update describes a Phase 2/Phase 3 study of LC-Z300-01 in Chinese patients with Type 2 diabetes mellitus, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LC-Z300-01

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Diabetes, Type 2 Diabetes | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING